Allogeneic hematopoietic SCT and mechanical heart valve: feasibility of reduced toxicity myeloablative conditioning.
Prébet
T
T
Devillier
R
R
Fürst
S
S
Vey
N
N
Blaise
D
D
D002872:Chromosome Deletion; D002897:Chromosomes, Human, Pair 7; D017809:Fatal Outcome; D005260:Female; D006338:Heart Neoplasms / Q000150:complications / Q000188:drug therapy / Q000601:surgery; D006350:Heart Valve Prosthesis; D006648:Histocompatibility; D006801:Humans; D008875:Middle Aged; D008943:Mitral Valve / Q000601:surgery; D009364:Neoplasm Recurrence, Local / Q000150:complications; D010198:Pancytopenia / Q000150:complications / Q000628:therapy; D036102:Peripheral Blood Stem Cell Transplantation; D012509:Sarcoma / Q000150:complications / Q000188:drug therapy / Q000601:surgery; D019172:Transplantation Conditioning / Q000379:methods*